Correction
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
N Engl J Med 2006; 354:2400-2401June 1, 2006
- Article
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension (Original Article, N Engl J Med 2005:353;2148 - 2157) . The appendix listing principal investigators and locations of centers participating in the Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group was inadvertently omitted from the article. It appears below.
Appendix
The members of the SUPER study group were as follows (in order of the number of patients enrolled at each center): A. Manes, Bologna, Italy; W. Seeger, Giessen, Germany; A. Fijalkowska, Warsaw, Poland; M.R. Kramer, Petach Tikva, Israel; A.J. Peacock, Glasgow, United Kingdom; O. Sitbon, Clamart, France; H. Al-hiti, Prague, Czech Republic; T. Pulido, Mexico City; I. Ben-Dov, Tel-Hashomer, Israel; A.E. Frost, Houston; D.L. Zwicke, Milwaukee; S.M. Shapiro, Los Angeles; A. Keogh, Darlinghurst, Australia; C. Ickinger, Johannesburg; R.P. Frantz, Rochester, Minn.; N.S. Hill, Boston; R.J. Ouduz, Torrance, Calif.; K. Karlocai, Budapest, Hungary; C.M. Yu, Hong Kong; A. Boonstra, Amsterdam; M.A. Gomez-Sanchez, Madrid; Melvyn Rubenfire, Ann Arbor, Mich.; J.A. Barbera, Barcelona; R.N. Channick, San Diego, Calif.; R. Naeije, Brussels; C. Marini, Pisa, Italy; E. Berman-Rosenzweig, New York; I.M. Robbins, Nashville; R.E. Girgis, Baltimore; V.F. Tapson, Durham, N.C.; M. Delcroix, Leuven, Belgium; D.G. Kiely, Sheffield, United Kingdom; J. Wodniecki, Zabrze, Poland; J. Schauer, Liepzig, Germany; M. Hoeper, Hannover, Germany; S.T. Lim, Singapore; S.-J. Tack, Suwon, South Korea; H. Reuter, Parow, South Africa; J. Carlsen, Copenhagen; C.C. Lang, Kuala Lumpur, Malaysia; A. Roman, Barcelona; R.L. Benza, Birmingham, Ala.; T.J. Williams, Melbourne, Australia; P.A. Corris, Newcastle upon Tyne, United Kingdom; J. Pepke Zaba, Cambridge, United Kingdom; D. Apro, Zalaegerszeg, Hungary; J.K. Ghali, Shreveport, La.; D.B. Badesch, Denver; S. Rich, Chicago; D.J. Ross, Los Angeles; I. Schulze-Neick, Berlin; G. Martensson, Goteborg, Sweden; A.A. Lopes, Sao Paulo; and A.K. Andreassen, Oslo.
- Citing Articles (1)
Citing Articles
1
Andreas Ambach, Won Seo, Bernd Bonnekoh, Harald Gollnick. (2009) Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil. Journal der Deutschen Dermatologischen Gesellschaft 7:10, 888-891
CrossRef
